Abstract:Objective: To conduct an updated systematic review and meta-analysis on the efficacy and safety of Chinese herbal medicine (CHM) for threatened miscarriage. Data Sources: Electronic databases were searched from inception to 30 June 2022. Study Eligibility Criteria: Only randomized controlled trials (RCTs) that assessed the efficacy and safety of CHM or combined CHM and Western medicine (CHM-WM) and compared with other treatments for threatened miscarriage were included for analysis. Methods: Three review authors independently evaluated included studies, assessed the risk of bias and extracted data for meta-analysis (continuation of pregnancy after 28 gestational weeks, continuation of pregnancy after treatment, preterm birth, adverse maternal outcomes, neonatal death, TCM syndrome severity, β-hCG levels after treatment), sensitivity analysis (β-hCG level) and subgroup analysis (TCM syndrome severity, β-hCG level). The risk ratio and 95% confidence interval were calculated by RevMan. Certainty of the evidence was assessed according to GRADE. Results: Overall, 57 RCTs involving 5,881 patients met the inclusion criteria. Compared with WM alone, CHM alone showed significant higher incidence of continuation of pregnancy after 28 gestational weeks (Risk Ratio (RR) 1.11; 95% CI 1.02 to 1.21; n = 1; moderate quality of evidence), continuation of pregnancy after treatment (RR 1.30; 95% CI 1.21 to 1.38; n = 10; moderate quality of evidence), higher β-hCG level (Standardized Mean Difference (SMD) 6.88; 95% CI 1.74 to 12.03; n = 4) and lower Traditional Chinese medicine (TCM) syndrome severity (SMD −2.94; 95% CI −4.27 to −1.61; n = 2). Compared with WM alone, combined CHM-WM showed significant higher incidence of continuation of pregnancy after 28 gestational weeks (RR 1.21; 95% CI 1.16 to 1.27; n = 15; moderate quality of evidence), continuation of pregnancy after treatment (RR 1.19; 95% CI 1.16 to 1.23; n = 41; moderate quality of evidence), higher β-hCG level (SMD 2.27; 95% CI 1.72 to 2.83; n = 37) and lower TCM syndrome severity (SMD −1.74; 95% CI −2.21 to −1.27; n = 15). No significant differences in reducing the adverse maternal outcomes and neonatal death were found in combined CHM-WM compared with WM alone (RR 0.97; 95% CI 0.62 to 1.52; n = 8; RR 0.39; 95% CI 0.12 to 1.21; n = 2). Conclusion: Current evidence supported CHM could be a potential treatment for threatened miscarriage. However, results should be interpreted with caution considering the low to moderate quality of the available evidence. Systematic Review Registration: [ https://inplasy.com/inplasy-2022-6-0107/ ], identifier [INPLASY20220107].

Tocolysis effects of traditional Chinese medicine and their effective components

Chinese Herbal Medicine for Induced Abortion in Early Pregnancy (before 14 Weeks’ Gestation)

The Effects of Acupuncture on Pregnancy Outcomes of in Vitro Fertilization with Embryo Transfer: an Interdisciplinary Systematic Review

Effect of Total Flavones from Cuscuta Chinensis on Anti-Abortion Via the MAPK Signaling Pathway

Systems Pharmacology-Based Research on the Mechanism of Tusizi-Sangjisheng Herb Pair in the Treatment of Threatened Abortion

Chemical profile and miscarriage prevention evaluation of Jiao-Ai Decoction, a classical traditional Chinese formula

Effect of baotaiyin on IL-23 /Th17 immune inflammatory axis in mouse model of spontaneous abortion

Ultrastructural Changes of Decidua and Chorion in Early Pregnant Women Contracepted by Mifepriston Combined with Heat Clearing Away and Hemostasis Removing Chinese Medicine

Queries on the article "Maternal traditional Chinese medicine exposure and risk of congenital malformations" and suggestions for teratogenicity research

Chinese herbal medicine for threatened miscarriage: An updated systematic review and meta-analysis

Treating Threatened Abortion with Chinese Herbs: a Case Report

The regulation of tolerogenic dendritic cells by a Chinese herb formula improves abortion prone in mice

Effects of quercetin on immune regulation at the maternal-fetal interface

Systematic Review of Chinese Medicine for Miscarriage During Early Pregnancy

Network Pharmacological Analysis and Molecular Docking of Huangqin-Baizhu Herb Pair in the Treatment of Threatened Abortion

Risk compounds, potential mechanisms and biomarkers of traditional Chinese medicine‐induced reproductive toxicity

The Efficacy of Traditional Chinese Medicine Shoutai Pill Combined with Western Medicine in the First Trimester of Pregnancy in Women with Unexplained Recurrent Spontaneous Abortion: A Systematic Review and Meta-Analysis

Complementary and Alternative Medicine for Threatened Miscarriage: Advantages and Risks

Traditional Chinese Medicine and Traditional Indonesian Medicine: A Comparative Review of Herbal Medicines Restricted in Pregnancy

Adverse Outcomes of Chinese Medicines Used for Threatened Miscarriage: a Systematic Review and Meta-Analysis

A Potential Mechanism of Kidney-Tonifying Herbs Treating Unexplained Recurrent Spontaneous Abortion: Clinical Evidence From the Homogeneity of Embryo Implantation and Tumor Invasion